CD8+ T cells can kill tumour cells by secreting large amounts of interferon-γ, tumour necrosis factor α and protease granzyme B. Therefore, CD8+ T cells compete for a very important role in anti-tumour immunity and are considered to be associated with a better prognosis for malignant tumour [54–56]. This evidence concerns the gene GZMB and neoplasm.